Company type,"Private (2004-13)
Public (2013-19)"
Traded as,Nasdaq: OMED
Industry,Pharmaceutical
Founded,University of Michigan
Founders,"Michael Clarke
Max Wicha"
Defunct,"April 23, 2019"
Fate,Acquired by Mereo BioPharma
Headquarters,"Redwood City, California, United States"
Key people,"Paul Hastings (CEO)
John Lewicki (R&D chief)
Chuck Alaimo (Operations director)"
Revenue,"US$24,700,000 (2012)"
Total assets,"US$207,600,000 [1] (2016)"
Number of employees,"83 (2013)
47 (2007)"
